MITSPA THOMAS: Open Payments
NPI 1477225340 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,681 in 72 payments from 21 companies in 2025. Trend: 2023 $730 · 2024 $1,649 · 2025 $1,681
Food & beverage: $1,597Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $353 |
| Madrigal Pharmaceuticals | 7 | $233 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $143 |
| Janssen Biotech, Inc. | 5 | $141 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $141 |
| Gilead Sciences, Inc. | 1 | $128 |
| Regeneron Healthcare Solutions, Inc. | 5 | $124 |
| GENZYME CORPORATION | 4 | $108 |
| QOL Medical, LLC | 2 | $51 |
| Novo Nordisk Inc | 2 | $39 |
Products named: REZDIFFRA, DUPIXENT, TREMFYA, XIFAXAN, SKYRIZI, Livdelzi, RINVOQ, ENTYVIO.
Industry payments across GA — which companies pay providers there.
